Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05541653 · ClinicalTrials.gov registry record · NA
The IGNITE Study on Concentrated Investment in Black Neighborhoods
A NA study of Health Behavior and Mental Health Wellness 1, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 571
- Enrollment target
- 1
- Study location
NCT05541653: Active NA study of Health Behavior and Mental Health Wellness 1, sponsored by University of Pennsylvania.
NCT05541653 is a NA study of Health Behavior and Mental Health Wellness 1 that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 571 participants, below the 2,177-participant average among 65 other Health Behavior trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05541653, a NA study of Health Behavior and Mental Health Wellness 1, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 571 participants
- Enrollment target
- 1
- Study location
Study Summary
Black Americans in the US fare worse across nearly every health indicator compared to White individuals. In Philadelphia, the location of this study, these health disparities culminate in a stark longevity gap, with average life expectancies in poor, predominantly Black neighborhoods being 20 years lower than in nearby affluent, predominantly White neighborhoods. The investigators will conduct a cluster randomized controlled trial (RCT) of a suite of place-based and financial-wellbeing interventions at the community, organization, and individual/household levels that address the social determinants of racial health disparities. At the community level, the investigators address underinvestment in Black neighborhoods by implementing vacant lot greening, abandoned house remediation, tree planting, and trash cleanup. At the organization level, the investigators partner with community-based financial empowerment providers to develop cross-organizational infrastructure to increase reach and maximize efficiency. At the individual/household levels, the investigators increase access to public benefits, financial counseling and tax preparation services, and emergency cash assistance. The investigators will test this "big push" intervention in 60 Black neighborhood microclusters, with a total of 720 adults. The investigators hypothesize that this "big push" intervention will have significant impact on overall health and wellbeing.
Primary Outcome
Composite index using method of Anderson (2008) based on three questions: rating of overall health (5-pt Likert ranging from poor to excellent); rating of how health has changed in last 6 months (better, same, worse); and number of days in the last 30 where physical or mental health precluded engagement in usual activities (self-care, work, recreation); (Oregon Health Insurance Experiment)
Conditions Studied
Interventions
- OTHER Financial Well-being Interventions
- OTHER Place-based Interventions
Study Locations (1)
Pennsylvania
- Philadelphia Neighborhoods - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 571 participants |
| Start Date | 2022-09-29 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05541653 still lists
NCT05541653 is an interventional study that assigns participants to a tested intervention. The registered 571 participants enrollment target is mid-sized for trials with a published cap, below the 2,177-participant average among 65 other Health Behavior trials with a reported enrollment target (74% lower).
The record links to 6 conditions, with Health Behavior appearing as the primary indexed condition, and to 2 interventions - of which Financial Well-being Interventions is the first listed.
NCT05541653 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05541653 about?
NCT05541653 is a clinical study titled "The IGNITE Study on Concentrated Investment in Black Neighborhoods". Black Americans in the US fare worse across nearly every health indicator compared to White individuals. In Philadelphia, the location of this study, these health disparities culminate in a stark longevity gap, with average life expectancies in poor, predominantly Black neighborhoods being 20 years ...
What is the current status of trial NCT05541653?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 571 participants. The study started on 2022-09-29. Estimated completion is 2026-06-30.
What conditions does trial NCT05541653 study?
This clinical trial studies the following conditions: Health Behavior, Mental Health Wellness 1, Environmental Exposure, Financial Stress, Economic Problems.
What interventions are being tested in trial NCT05541653?
The interventions under investigation include: Financial Well-being Interventions (OTHER), Place-based Interventions (OTHER).
Who is sponsoring clinical trial NCT05541653?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05541653 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05541653's enrollment target sits among peer trials
571 18th of 65 higher than 48 of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sugary Drink Labeling Study
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Validation Study of Bioelectronics
RECRUITING · NA
-
A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04410796 · 571 participants · Phase 2
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
- NCT05131022 · 572 participants · Phase 1
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- NCT06346392 · 572 participants · Phase 3
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
- NCT06615050 · 572 participants · Phase 3
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI